Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation


July, 2015

Clinical Trial

Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.

Boynton GE, Raoof D, Niziol LM, Hussain M, Mian SI.

Cornea. 2015 Jul;34(7):725-32.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive